Discoid Lupus Erythematosus — Clinical Trials

MONDO:00195582 active·2 recruitingLast updated: Mar 16, 2026, 3:46 AM

Trial Landscape

Discoid Lupus Erythematosus has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

By Approach

Drug Treatment2

Procedure1

1 additional trials involve behavioral, dietary, diagnostic, or observational approaches.

By Phase

Phase 1

Phase 2

Sponsor Types

Academic/Other1Industry1

Top Sponsors

Bristol-Myers Squibb

Trial Locations

Canada1 trial

United States1 trial

Argentina1 trial

Bulgaria1 trial

Germany1 trial

Mexico1 trial

Netherlands1 trial

Poland1 trial

Romania1 trial

Spain1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

2 Trials

Phase 2Recruiting

NCT06261021

Study to Evaluate the Efficacy of Ruxolitinib 1.5% Cream in Adult Subjects with Discoid Lupus Erythematosus

Sponsor:Innovaderm Research Inc.

CanadaStarted: Apr 2024Est. completion: Feb 2026Updated: Mar 2025

Phase 1Recruiting

NCT06013995

A Study to Investigate the Safety, Tolerability, Drug Levels and Drug Effects of BMS-986326 in Adult Participants With Different Forms of Lupus

Sponsor:Bristol-Myers Squibb

United StatesStarted: Sep 2023Est. completion: Apr 2026Updated: Mar 2026

Stay informed about clinical trials for Discoid Lupus Erythematosus.

Follow this disease to get updates when trials open, close, or change status.

Follow This Disease — Free

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 3:46 AM